Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01461265 · ClinicalTrials.gov registry record · Phase 1
Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases
A Phase 1 study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 29
- Enrollment target
NCT01461265: Completed Phase 1 study, sponsored by Boston Scientific Corporation.
NCT01461265 is a Phase 1 study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 29 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (52% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01461265, a Phase 1 study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 29 participants
- Enrollment target
Study Summary
This study will evaluate the safety and efficacy of cryoablation therapy for relief of pain associated with metastatic bone tumors.
Primary Outcome
The endpoint for this study will be measured as follows: assessment of the effectiveness of cryoablation associated with palliation of pain in subjects with metastatic bone cancer by measuring the average difference of pre- and posttreatment worst pain in 24 hours from baseline to 24 hour, 1, 4, 12, and 24 week follow-up intervals as measured on the numeric 0 to 10 Brief Pain Inventory (BPI) scale.
Interventions
- PROCEDURE Cryoablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2011-11 |
| Est. Completion | 2015-04 |
| Phase | Phase 1 |
What the finished NCT01461265 record still lists
NCT01461265 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (52% lower).
The record links to 0 conditions, and to 1 intervention - of which Cryoablation is the first listed.
NCT01461265 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01461265 about?
NCT01461265 is a clinical study titled "Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases". This study will evaluate the safety and efficacy of cryoablation therapy for relief of pain associated with metastatic bone tumors.
What is the current status of trial NCT01461265?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 29 participants. The study started on 2011-11. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01461265?
The interventions under investigation include: Cryoablation (PROCEDURE).
Who is sponsoring clinical trial NCT01461265?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01461265's enrollment target sits among peer trials
29 1440th of 2000 higher than 554 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia